402 related articles for article (PubMed ID: 32688057)
1. Clinical and molecular description of 19 patients with GATAD2B-Associated Neurodevelopmental Disorder (GAND).
Vera G; Sorlin A; Delplancq G; Lecoquierre F; Brasseur-Daudruy M; Petit F; Smol T; Ziegler A; Bonneau D; Colin E; Mercier S; Cogné B; Bézieau S; Edery P; Lesca G; Chatron N; Sabatier I; Duban-Bedu B; Colson C; Piton A; Durand B; Capri Y; Perrin L; Wiesener A; Zweier C; Maroofian R; Carroll CJ; Galehdari H; Mazaheri N; Callewaert B; Giulianno F; Zaafrane-Khachnaoui K; Buchert-Lo R; Haack T; Magg J; Rieß A; Blandfort M; Waldmüller S; Horber V; Leonardi E; Polli R; Turolla L; Murgia A; Frebourg T; Lebre AS; Nicolas G; Saugier-Veber P; Guerrot AM
Eur J Med Genet; 2020 Oct; 63(10):104004. PubMed ID: 32688057
[TBL] [Abstract][Full Text] [Related]
2. GATAD2B-associated neurodevelopmental disorder (GAND): clinical and molecular insights into a NuRD-related disorder.
Shieh C; Jones N; Vanle B; Au M; Huang AY; Silva APG; Lee H; Douine ED; Otero MG; Choi A; Grand K; Taff IP; Delgado MR; Hajianpour MJ; Seeley A; Rohena L; Vernon H; Gripp KW; Vergano SA; Mahida S; Naidu S; Sousa AB; Wain KE; Challman TD; Beek G; Basel D; Ranells J; Smith R; Yusupov R; Freckmann ML; Ohden L; Davis-Keppen L; Chitayat D; Dowling JJ; Finkel R; Dauber A; Spillmann R; Pena LDM; ; Metcalfe K; Splitt M; Lachlan K; McKee SA; Hurst J; Fitzpatrick DR; Morton JEV; Cox H; Venkateswaran S; Young JI; Marsh ED; Nelson SF; Martinez JA; Graham JM; Kini U; Mackay JP; Pierson TM
Genet Med; 2020 May; 22(5):878-888. PubMed ID: 31949314
[TBL] [Abstract][Full Text] [Related]
3. Intellectual disability due to monoallelic variant in GATAD2B and mosaicism in unaffected parent.
Rabin R; Millan F; Cabrera-Luque J; Pappas J
Am J Med Genet A; 2018 Dec; 176(12):2907-2910. PubMed ID: 30346093
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation in the GATAD2B gene associated with severe intellectual disability.
Ueda K; Yanagi K; Kaname T; Okamoto N
Brain Dev; 2019 Mar; 41(3):276-279. PubMed ID: 30482549
[TBL] [Abstract][Full Text] [Related]
5. Gatad2b, associated with the neurodevelopmental syndrome GAND, plays a critical role in neurodevelopment and cortical patterning.
Abad C; Robayo MC; Muñiz-Moreno MDM; Bernardi MT; Otero MG; Kosanovic C; Griswold AJ; Pierson TM; Walz K; Young JI
Transl Psychiatry; 2024 Jan; 14(1):33. PubMed ID: 38238293
[TBL] [Abstract][Full Text] [Related]
6. GATAD2B loss-of-function mutations cause a recognisable syndrome with intellectual disability and are associated with learning deficits and synaptic undergrowth in Drosophila.
Willemsen MH; Nijhof B; Fenckova M; Nillesen WM; Bongers EM; Castells-Nobau A; Asztalos L; Viragh E; van Bon BW; Tezel E; Veltman JA; Brunner HG; de Vries BB; de Ligt J; Yntema HG; van Bokhoven H; Isidor B; Le Caignec C; Lorino E; Asztalos Z; Koolen DA; Vissers LE; Schenck A; Kleefstra T
J Med Genet; 2013 Aug; 50(8):507-14. PubMed ID: 23644463
[TBL] [Abstract][Full Text] [Related]
7. GATAD2B-related intellectual disability due to parental mosaicism and review of literature.
Kaur P; Mishra S; Rajesh SM; Girisha KM; Shukla A
Clin Dysmorphol; 2019 Oct; 28(4):190-194. PubMed ID: 31205050
[TBL] [Abstract][Full Text] [Related]
8. Expanding the clinical phenotype and genetic spectrum of PURA-related neurodevelopmental disorders.
Choi SA; Lee HS; Park TJ; Park S; Ko YJ; Kim SY; Lim BC; Kim KJ; Chae JH
Brain Dev; 2021 Oct; 43(9):912-918. PubMed ID: 34116881
[TBL] [Abstract][Full Text] [Related]
9. The NuRD complex and macrocephaly associated neurodevelopmental disorders.
Pierson TM; Otero MG; Grand K; Choi A; Graham JM; Young JI; Mackay JP
Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):548-556. PubMed ID: 31737996
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific DNase I footprint analysis confirms the association of
Nikam V; Shaik Mohammad N
J Genet; 2021; 100():. PubMed ID: 34470925
[TBL] [Abstract][Full Text] [Related]
11. Expanding the phenotype of ASXL3-related syndrome: A comprehensive description of 45 unpublished individuals with inherited and de novo pathogenic variants in ASXL3.
Schirwani S; Albaba S; Carere DA; Guillen Sacoto MJ; Milan Zamora F; Si Y; Rabin R; Pappas J; Renaud DL; Hauser N; Reid E; Blanchet P; Foulds N; Dixit A; Fisher R; Armstrong R; Isidor B; Cogne B; Schrier Vergano S; Demirdas S; Dykzeul N; Cohen JS; Grand K; Morel D; Slavotinek A; Albassam HF; Naik S; Dean J; Ragge N; Costa C; Tedesco MG; Harrison RE; Bouman A; Palen E; Challman TD; Willemsen MH; Vogt J; Cunniff C; Bergstrom K; Walia JS; Bruel AL; Kini U; Alkuraya FS; Slegesky V; Meeks N; Girotto P; Johnson D; ; Newbury-Ecob R; Ockeloen CW; Prontera P; Lynch SA; Li D; Graham JM; Pierson TM; Balasubramanian M
Am J Med Genet A; 2021 Nov; 185(11):3446-3458. PubMed ID: 34436830
[TBL] [Abstract][Full Text] [Related]
12. De novo missense variants in HECW2 are associated with neurodevelopmental delay and hypotonia.
Berko ER; Cho MT; Eng C; Shao Y; Sweetser DA; Waxler J; Robin NH; Brewer F; Donkervoort S; Mohassel P; Bönnemann CG; Bialer M; Moore C; Wolfe LA; Tifft CJ; Shen Y; Retterer K; Millan F; Chung WK
J Med Genet; 2017 Feb; 54(2):84-86. PubMed ID: 27389779
[TBL] [Abstract][Full Text] [Related]
13. Novel GATAD2B loss-of-function mutations cause intellectual disability in two unrelated cases.
Luo X; Zou Y; Tan B; Zhang Y; Guo J; Zeng L; Zhang R; Tan H; Wei X; Hu Y; Zheng Y; Liang D; Wu L
J Hum Genet; 2017 Apr; 62(4):513-516. PubMed ID: 28077840
[TBL] [Abstract][Full Text] [Related]
14. Variants in GNAI1 cause a syndrome associated with variable features including developmental delay, seizures, and hypotonia.
Muir AM; Gardner JF; van Jaarsveld RH; de Lange IM; van der Smagt JJ; Wilson GN; Dubbs H; Goldberg EM; Zitano L; Bupp C; Martinez J; Srour M; Accogli A; Alhakeem A; Meltzer M; Gropman A; Brewer C; Caswell RC; Montgomery T; McKenna C; McKee S; Powell C; Vasudevan PC; Brady AF; Joss S; Tysoe C; Noh G; Tarnopolsky M; Brady L; Zafar M; Schrier Vergano SA; Murray B; Sawyer L; Hainline BE; Sapp K; DeMarzo D; Huismann DJ; Wentzensen IM; Schnur RE; Monaghan KG; Juusola J; Rhodes L; Dobyns WB; Lecoquierre F; Goldenberg A; Polster T; Axer-Schaefer S; Platzer K; Klöckner C; Hoffman TL; MacArthur DG; O'Leary MC; VanNoy GE; England E; Varghese VC; Mefford HC
Genet Med; 2021 May; 23(5):881-887. PubMed ID: 33473207
[TBL] [Abstract][Full Text] [Related]
15. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
Mol Autism; 2019; 10():35. PubMed ID: 31649809
[TBL] [Abstract][Full Text] [Related]
16. De Novo Mutations of CCNK Cause a Syndromic Neurodevelopmental Disorder with Distinctive Facial Dysmorphism.
Fan Y; Yin W; Hu B; Kline AD; Zhang VW; Liang D; Sun Y; Wang L; Tang S; Powis Z; Li L; Yan H; Shi Z; Yang X; Chen Y; Wang J; Jiang Y; Tan H; Gu X; Wu L; Yu Y
Am J Hum Genet; 2018 Sep; 103(3):448-455. PubMed ID: 30122539
[TBL] [Abstract][Full Text] [Related]
17. Expanding the phenotype of intellectual disability caused by HIVEP2 variants.
Goldsmith H; Wells A; Sá MJN; Williams M; Heussler H; Buckman M; Pfundt R; de Vries BBA; Goel H
Am J Med Genet A; 2019 Sep; 179(9):1872-1877. PubMed ID: 31207095
[TBL] [Abstract][Full Text] [Related]
18. A novel likely pathogenic heterozygous HECW2 missense variant in a family with variable expressivity of neurodevelopmental delay, hypotonia, and epileptiform EEG patterns.
Heide EC; Puk O; Biskup S; Krahn A; Rauf E; Kreilkamp BAK; Paulus W; Focke NK
Am J Med Genet A; 2021 Dec; 185(12):3838-3843. PubMed ID: 34327820
[TBL] [Abstract][Full Text] [Related]
19. The CHD4-related syndrome: a comprehensive investigation of the clinical spectrum, genotype-phenotype correlations, and molecular basis.
Weiss K; Lazar HP; Kurolap A; Martinez AF; Paperna T; Cohen L; Smeland MF; Whalen S; Heide S; Keren B; Terhal P; Irving M; Takaku M; Roberts JD; Petrovich RM; Schrier Vergano SA; Kenney A; Hove H; DeChene E; Quinonez SC; Colin E; Ziegler A; Rumple M; Jain M; Monteil D; Roeder ER; Nugent K; van Haeringen A; Gambello M; Santani A; Medne L; Krock B; Skraban CM; Zackai EH; Dubbs HA; Smol T; Ghoumid J; Parker MJ; Wright M; Turnpenny P; Clayton-Smith J; Metcalfe K; Kurumizaka H; Gelb BD; Baris Feldman H; Campeau PM; Muenke M; Wade PA; Lachlan K
Genet Med; 2020 Feb; 22(2):389-397. PubMed ID: 31388190
[TBL] [Abstract][Full Text] [Related]
20. Pathogenic variants in USP7 cause a neurodevelopmental disorder with speech delays, altered behavior, and neurologic anomalies.
Fountain MD; Oleson DS; Rech ME; Segebrecht L; Hunter JV; McCarthy JM; Lupo PJ; Holtgrewe M; Moran R; Rosenfeld JA; Isidor B; Le Caignec C; Saenz MS; Pedersen RC; Morgan TM; Pfotenhauer JP; Xia F; Bi W; Kang SL; Patel A; Krantz ID; Raible SE; Smith W; Cristian I; Torti E; Juusola J; Millan F; Wentzensen IM; Person RE; Küry S; Bézieau S; Uguen K; Férec C; Munnich A; van Haelst M; Lichtenbelt KD; van Gassen K; Hagelstrom T; Chawla A; Perry DL; Taft RJ; Jones M; Masser-Frye D; Dyment D; Venkateswaran S; Li C; Escobar LF; Horn D; Spillmann RC; Peña L; Wierzba J; Strom TM; Parenti I; Kaiser FJ; Ehmke N; Schaaf CP
Genet Med; 2019 Aug; 21(8):1797-1807. PubMed ID: 30679821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
